The global regenerative medicine market is set to witness explosive growth, with its valuation expected to surge from US$ 13,385.6 million in 2023 to an impressive US$ 73,084.2 million by 2033, according to the latest industry analysis. This reflects a robust compound annual growth rate (CAGR) of 18.5% over the forecast period. The rise in …
Category Archives: Healthcare Trends
Veterinary Molecular Diagnostics Market to Double in Value, Reaching USD 377.22 Million by 2033 at a 6.84% of CAGR
The global veterinary molecular diagnostics market is poised for significant growth, with its valuation projected to rise from US$ 194.47 million in 2023 to US$ 377.22 million by 2033. This represents a compound annual growth rate (CAGR) of 6.84% over the forecast period, according to the latest industry analysis. The increasing demand for fast and …
Pharmaceutical Excipient Market to Reach USD 1,600.0 Million by 2034 at a 5.1% of CAGR , Driven by Rising Demand for Advanced Drug Formulations
Future Market Insights (FMI) has released an updated analysis of the pharmaceutical excipient market, projecting steady growth over the next decade. The market is expected to be valued at US$ 972.9 million in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 5.1%, reaching a valuation of US$ 1.6 billion …
Joint Replacement Market to Hit USD 27 Billion by 2032 at a 4.3% of CAGR, Driven by Demand for Knee Replacement Procedures
The global joint replacement market is poised for substantial growth, with its valuation projected to rise from US$ 17.1 billion in 2021 to US$ 27 billion by 2032, according to a newly released analysis report by Future Market Insights. This expansion represents a compound annual growth rate (CAGR) of 4.3% from 2022 to 2032. The …
Antacids Market Value Rise to Reach USD 11,194.8 Million by 2033 with a 4.9% of CAGR
The global antacids market is set to experience steady growth, with its valuation projected to rise from US$ 6,971.2 million in 2023 to US$ 11,194.8 million by 2033, according to a recent report by Future Market Insights. This represents a compound annual growth rate (CAGR) of 4.9% over the forecast period. The rising prevalence of …
Global Retinal Biologics Market to Reach USD 41.92 Billion by 2028, Surging at 11.1% CAGR
The global retinal biologics market has experienced remarkable growth, with total revenue reaching USD 22.25 billion in 2022. This growth trajectory is projected to continue, as the market is set to reach an impressive USD 41.92 billion by 2028, fueled by a robust compound annual growth rate (CAGR) of 11.1% during the forecast period from …
Prurigo Nodularis Treatment Market to Reach USD 930.9 Million by 2033 with a 3.0% CAGR
The global prurigo nodularis treatment market is projected to grow steadily, with its valuation expected to rise from US$ 693.3 million in 2023 to US$ 930.9 million by 2033, according to a Future Market Insights report. This growth represents a compound annual growth rate (CAGR) of 3.0% over the forecast period. Increased awareness of rare …
Global DNA Sequencing Services Market Set to Surpass USD 2,080.2 million by 2033 Amid Rising Cancer Cases | FMI
The global DNA sequencing services market is witnessing remarkable growth, with a valuation of USD 945.6 million in 2023 and a projected compound annual growth rate (CAGR) of 8.2% over the next decade. By 2033, the market is expected to reach an impressive valuation of USD 2,080.2 million, driven by increasing demand and advancements in …
Neurotrophic Keratitis Treatment Market to Double in Value, Reaching USD 10 Billion by 2033 at a 7.17% CAGR
The global neurotrophic keratitis treatment market is on a trajectory of substantial growth, with its valuation expected to rise from US$ 5 billion in 2023 to an impressive US$ 10 billion by 2033. This reflects a compound annual growth rate (CAGR) of 7.17% over the forecast period, according to Future Market Insights. The surge in …
Point-of-Care Molecular Diagnostics Market Expected to Reach USD 11.1 Billion by 2033, Growing at a 9.7% CAGR
The point-of-care molecular diagnostics market is predicted to secure a valuation of USD 4.4 billion in 2023 and is rising to USD 11.1 billion by 2033. The market is estimated at a CAGR of 9.7% during the forecast period. Rising infectious and chronic diseases, such as cardiovascular, diabetes, and COVID-19, are increasing the adoption of point-of-care molecular diagnostics. …